To include your compound in the COVID-19 Resource Center, submit it here.
Infectious disease company Arsanis Inc. (Waltham, Mass.) raised $45.5 million in a series D round led by the Bill
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury